Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1973 Jan 31;137(2):411–423. doi: 10.1084/jem.137.2.411

IMMUNOLOGIC REACTIONS TO HAPTENS ON AUTOLOGOUS CARRIERS

I. PARTICIPATION OF BOTH THYMUS-DERIVED AND BONE MARROW-DERIVED CELLS IN THE SECONDARY IN VITRO RESPONSE

John W Moorhead 1, Curla S Walters 1, Henry N Claman 1
PMCID: PMC2139497  PMID: 4119590

Abstract

Both thymus-derived (T) and bone marrow-derived (B) lymphocytes participate in the response to a hapten 4-hydroxy-3-iodo-5-nitrophenylacetic acid (NIP), coupled to a nonimmunogenic isologous carrier, mouse gamma globulin (MGG). Spleen cells from mice immunized with NIP-MGG show increased DNA synthesis in vitro when cultured with NIP-MGG. The participation of and requirement for T cells in the response was demonstrated by treating the spleen cells with anti-θ serum. This treatment resulted in a 77% inhibition of the antigen response. Furthermore, adoptively transferred normal thymus cells could be specifically "activated" by NIP-MGG in vivo and they responded secondarily to the antigen in vitro. The active participation of B cells in the secondary response was demonstrated by passing the immune spleen cells through a column coated with polyvalent anti-MGG serum. Column filtration reduced the number of NIP-specific plaque-forming cells and NIP-specific rosette-forming cells (both functions of B cells) and produced a 47% inhibition of the NIP-MGG response. The ability of the cells to respond to phytohemagglutinin (PHA) was not affected by column filtration showing that T cells were not being selectively removed. The participation of B cells in the in vitro NIP-MGG response was also shown by treatment of the spleen cells with antiserum specific for MGG and MGG determinants. B cells were removed by treatment with anti-IgM or polyvalent anti-MGG serum plus complement, resulting in a respective 46 and 49% inhibition of the response to NIP-MGG. (Treatment with anti-IgM serum had no effect on T cells.) The contribution of the hapten NIP to stimulation of T cells was investigated using NIP-MGG-activated thymus cells. These activated T cells responded in vitro very well to the NIP-MGG complex but not to the MGG carrier alone demonstrating the requirement of the hapten for T cell stimulation. The response was also partially inhibited (41%) by incubating the activated cells with NIP coupled to a single amino acid (epsilon-aminocaproic acid) before addition of NIP-MGG. These results demonstrated that T cells recognize the hapten NIP when it is coupled to the isologous carrier MGG.

Full Text

The Full Text of this article is available as a PDF (953.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brownstone A., Mitchison N. A., Pitt-Rivers R. Chemical and serological studies with an iodine-containing synthetic immunological determinant 4-hydroxy-3-iodo-5-nitrophenylacetic acid (NIP) and related compounds. Immunology. 1966 May;10(5):465–479. [PMC free article] [PubMed] [Google Scholar]
  2. Cheers C., Breitner J. C., Little M., Miller J. F. Cooperation between carrier-reactive and hapten-sensitive cells in vitro. Nat New Biol. 1971 Aug 25;232(34):248–250. doi: 10.1038/newbio232248a0. [DOI] [PubMed] [Google Scholar]
  3. Claman H. N., Chaperon E. A. Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence. Transplant Rev. 1969;1:92–113. doi: 10.1111/j.1600-065x.1969.tb00137.x. [DOI] [PubMed] [Google Scholar]
  4. Crone M., Koch C., Simonsen M. The elusive T cell receptor. Transplant Rev. 1972;10:36–56. doi: 10.1111/j.1600-065x.1972.tb01538.x. [DOI] [PubMed] [Google Scholar]
  5. Golan D. T., Borel Y. Nonantigenicity and immunologic tolerance: the role of the carrier in the induction of tolerance to the hapten. J Exp Med. 1971 Oct 1;134(4):1046–1061. doi: 10.1084/jem.134.4.1046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Golstein P., Wigzell H., Blomgren H., Svedmyr E. A. Cells mediating specific in vitro cytotoxicity. II. Probable autonomy of thymus-processed lymphocytes (T cells) for the killing of allogeneic target cells. J Exp Med. 1972 Apr 1;135(4):890–906. doi: 10.1084/jem.135.4.890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Greaves M. F. The expression of immunoglobulin determinants on the surface of antigen-binding lymphoid cells in mice. I. An analysis of light and heavy chain restrictions on individual cells. Eur J Immunol. 1971 Jun;1(3):186–194. doi: 10.1002/eji.1830010308. [DOI] [PubMed] [Google Scholar]
  8. Iverson G. M. Ability of CBA mice to produce anti-idiotypic sera to 5563 myeloma protein. Nature. 1970 Jul 18;227(5255):273–274. doi: 10.1038/227273a0. [DOI] [PubMed] [Google Scholar]
  9. Jones G., Torrigiani G., Roitt I. M. Immunoglobulin determinants on mouse lymphocytes. J Immunol. 1971 Jun;106(6):1425–1430. [PubMed] [Google Scholar]
  10. Katz D. H., Benacerraf B. The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol. 1972;15:1–94. doi: 10.1016/s0065-2776(08)60683-5. [DOI] [PubMed] [Google Scholar]
  11. Miller J. F., Mitchell G. F. Thymus and antigen-reactive cells. Transplant Rev. 1969;1:3–42. doi: 10.1111/j.1600-065x.1969.tb00135.x. [DOI] [PubMed] [Google Scholar]
  12. Mitchison N. A. Mechanism of action of antilymphocyte serum. Fed Proc. 1970 Jan-Feb;29(1):222–223. [PubMed] [Google Scholar]
  13. Moorhead J. W., Claman H. N. Thymus-derived lymphocytes and hydrocortisone: identification of subsets of theta-bearing cells and redistribution to bone marrow. Cell Immunol. 1972 Sep;5(1):74–86. doi: 10.1016/0008-8749(72)90085-8. [DOI] [PubMed] [Google Scholar]
  14. Pasanen V. J., Mäkelä O. Effect of the number of haptens coupled to each erythrocyte on haemolytic plaque formation. Immunology. 1969 Mar;16(3):399–407. [PMC free article] [PubMed] [Google Scholar]
  15. Rabellino E., Colon S., Grey H. M., Unanue E. R. Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation. J Exp Med. 1971 Jan 1;133(1):156–167. doi: 10.1084/jem.133.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Raff M. C. Surface antigenic markers for distinguishing T and B lymphocytes in mice. Transplant Rev. 1971;6:52–80. doi: 10.1111/j.1600-065x.1971.tb00459.x. [DOI] [PubMed] [Google Scholar]
  17. Rittenberg M. B., Pratt K. L. Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen. Proc Soc Exp Biol Med. 1969 Nov;132(2):575–581. doi: 10.3181/00379727-132-34264. [DOI] [PubMed] [Google Scholar]
  18. Takahashi T., Old L. J., McIntire K. R., Boyse E. A. Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med. 1971 Oct 1;134(4):815–832. doi: 10.1084/jem.134.4.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Taylor R. B., Iverson G. M. Hapten competition and the nature of cell-cooperation in the antibody response. Proc R Soc Lond B Biol Sci. 1971 Jan 12;176(1045):393–418. doi: 10.1098/rspb.1971.0003. [DOI] [PubMed] [Google Scholar]
  20. Vitetta E. S., Bianco C., Nussenzweig V., Uhr J. W. Cell surface immunoglobulin. IV. Distribution among thymocytes, bone mrrow cells, and their derived populations. J Exp Med. 1972 Jul 1;136(1):81–93. doi: 10.1084/jem.136.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Walters C. S., Moorhead J. W., Claman H. N. Immunity tolerance to a hapten (NIP) coupled to an isologous carrier (mouse gamma globulin). J Exp Med. 1972 Sep 1;136(3):546–555. doi: 10.1084/jem.136.3.546. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES